Suppr超能文献

相似文献

1
Paracrine functions of fibrocytes to promote lung fibrosis.
Expert Rev Respir Med. 2014 Apr;8(2):163-72. doi: 10.1586/17476348.2014.862154. Epub 2014 Jan 22.
3
Fibrocytes in pulmonary fibrosis: a brief synopsis.
Eur Respir Rev. 2013 Dec;22(130):552-7. doi: 10.1183/09059180.00007713.
4
Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice.
J Appl Physiol (1985). 2011 Jul;111(1):285-94. doi: 10.1152/japplphysiol.00201.2010. Epub 2011 Jan 13.
5
An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis.
J Pathol. 2018 Aug;245(4):399-409. doi: 10.1002/path.5092. Epub 2018 Jun 5.
6
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Int J Biochem Cell Biol. 2008;40(10):2129-40. doi: 10.1016/j.biocel.2008.02.012. Epub 2008 Mar 11.
7
Fibrocytes in lung disease.
J Leukoc Biol. 2007 Sep;82(3):449-56. doi: 10.1189/jlb.0906587. Epub 2007 Jun 5.
8
Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.
Am J Respir Crit Care Med. 2015 Feb 15;191(4):427-36. doi: 10.1164/rccm.201407-1334OC.
9
Tissue fibrocytes are a subpopulation of macrophages.
Am J Respir Cell Mol Biol. 2015 Jan;52(1):138. doi: 10.1165/rcmb.2014-0151LE.
10
[The role of fibrocytes in pulmonary fibrosis].
Pol Merkur Lekarski. 2014 Jan;36(211):39-41.

引用本文的文献

2
GPCRs and fibroblast heterogeneity in fibroblast-associated diseases.
FASEB J. 2023 Aug;37(8):e23101. doi: 10.1096/fj.202301091.
3
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.
Int J Mol Sci. 2023 Feb 5;24(4):3149. doi: 10.3390/ijms24043149.
6
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis.
Kidney Dis (Basel). 2020 Jul;6(4):226-235. doi: 10.1159/000505295. Epub 2020 Mar 26.
7
Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through αβ Integrin.
Am J Respir Cell Mol Biol. 2020 Nov;63(5):613-622. doi: 10.1165/rcmb.2020-0150OC.
8
Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis.
Am J Respir Cell Mol Biol. 2020 May;62(5):622-632. doi: 10.1165/rcmb.2019-0297OC.
10
Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy.
Front Pharmacol. 2019 May 17;10:532. doi: 10.3389/fphar.2019.00532. eCollection 2019.

本文引用的文献

3
4
A review of current and novel therapies for idiopathic pulmonary fibrosis.
J Thorac Dis. 2013 Feb;5(1):48-73. doi: 10.3978/j.issn.2072-1439.2012.12.07.
5
Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis.
PLoS One. 2013;8(1):e53736. doi: 10.1371/journal.pone.0053736. Epub 2013 Jan 16.
7
Strategies for anti-fibrotic therapies.
Biochim Biophys Acta. 2013 Jul;1832(7):1088-103. doi: 10.1016/j.bbadis.2012.12.007. Epub 2012 Dec 21.
8
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis.
Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S24. doi: 10.1186/1755-1536-5-S1-S24. eCollection 2012.
10
The fibrotic matrix in control: does the extracellular matrix drive progression of idiopathic pulmonary fibrosis?
Am J Respir Crit Care Med. 2012 Nov 1;186(9):814-6. doi: 10.1164/rccm.201208-1561ED.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验